L. Landuzzi

发表

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

F. Pappalardo, S. Motta, P. Lollini, 2010, Cancer research.

Cancer esearch rated Systems and Technologies : Mathematical Oncology ilico Modeling and In vivo Efficacy of R cer-Preventive Vaccinations

F. Pappalardo, S. Motta, P. Lollini, 2010 .

C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.

P. Lollini, P. Picci, F. Bertoni, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis

G. Benegiamo, P. Lollini, M. Iezzi, 2015, Breast Cancer Research.

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER‐2/neu transgenic mice

P. Musiani, P. Lollini, W. Muller, 1998, International journal of cancer.

Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA).

P. Lollini, K. Scotlandi, P. Nanni, 1989, Anticancer research.

IFN-γ and CD38 in Hyperprogressive Cancer Development

P. Lollini, A. Ardizzoni, P. Nanni, 2021, Cancers.

Immunological Prevention of a Multigene Cancer Syndrome

P. Musiani, P. Lollini, G. Forni, 2004, Cancer Research.

B Cell Dependent and γ Transgenic Mice Is IFN-neu in HER-2 / Immunoprevention of Mammary Carcinoma and PierLuigi Lollini

P. Musiani, G. Forni, M. Iezzi, 2004 .

Prevention of HER‐2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12

P. Musiani, P. Lollini, G. Forni, 2003, International journal of cancer.

Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER‐2/neu oncogene‐driven animal model system

K. Shin‐ya, B. Seliger, P. Lollini, 2010, Proteomics.

Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus

P. Lollini, M. Iezzi, P. Nanni, 2013, PLoS pathogens.

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

S. Bicciato, M. Iezzi, M. Arigoni, 2014, BMC Genomics.

Carcinomas in Transgenic BALB / c Mice Carcinogenesis Than Transplantable p 185 More Effectively Inhibits DNA Vaccination Against Rat Her-2 / Neu Musiani and

P. Musiani, P. Lollini, M. Colombo, 2000 .

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy

P. Lollini, P. Nanni, C. De Giovanni, 2021, Cells.

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas

P. Lollini, P. Picci, M. Magnani, 2014, BMC Cancer.

Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma

P. Lollini, A. Bazzocchi, K. Scotlandi, 2020, Journal of Cell Communication and Signaling.

p185neu protein is required for tumor and anchorage‐independent growth, not for cell proliferation of transgenic mammary carcinoma

S. Ménard, P. Musiani, P. Lollini, 2000, International journal of cancer.

Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft

P. Lollini, D. Santini, M. Arigoni, 2021, Scientific Reports.

Virus-like particle display of HER2 induces potent anti-cancer responses

M. Penichet, T. Theander, P. Lollini, 2018, Oncoimmunology.

CD99 acts as an oncosuppressor in osteosarcoma.

P. Lollini, M. Colombo, P. Picci, 2006, Molecular biology of the cell.

Immunoprevention and Immunotherapy of Mammary Carcinoma

P. Lollini, P. Nanni, C. De Giovanni, 2010, The breast journal.

HER/erbB Receptors as Therapeutic Targets of Immunotoxins in Human Rhabdomyosarcoma Cells

L. Polito, A. Bolognesi, P. Lollini, 2002, Journal of immunotherapy.

TRAF6 regulates proliferation and differentiation of skeletal myoblasts.

P. Lollini, K. Klingel, L. Landuzzi, 2011, Differentiation; research in biological diversity.

RIP2 regulates growth and differentiation of normal myoblasts and of rhabdomyosarcoma cells.

P. Lollini, L. Landuzzi, B. Munz, 2008, European journal of cell biology.

Systemic effects of cytokines released by gene‐transduced tumor cells: Marked hyperplasia induced in small bowel by γ‐interferon transfectants through host lymphocytes

P. Lollini, W. Grigioni, P. Nanni, 1995, International journal of cancer.

Expression of HER/erbb family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells

S. Ménard, P. Lollini, K. Scotlandi, 2000, International journal of cancer.

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice

P. Lollini, M. Iezzi, P. Nanni, 2012, British Journal of Cancer.

Inhibition of Connective Tissue Growth Factor (CTGF/CCN2) Expression Decreases the Survival and Myogenic Differentiation of Human Rhabdomyosarcoma Cells

P. Lollini, P. Nanni, C. De Giovanni, 2004, Cancer Research.

Ewing Sarcoma PDX Models.

D. Surdez, K. Scotlandi, M. Manara, 2020, Methods in molecular biology.

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations

M. Ferracin, P. Lollini, P. Picci, 2019, Scientific Reports.

Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.

P. Musiani, P. Lollini, M. Iezzi, 2003, Cancer research.

Therapy of murine mammary carcinoma metastasis with interferon gamma and MHC gene-transduced tumour cells.

P. Lollini, G. Forni, P. Nanni, 1996, British Journal of Cancer.

APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivo.

I. Fong, K. Brown, A. Gescher, 2009, European journal of cancer.

INTERLEUKIN 6 GENE‐TRANSFECTED MOUSE MAMMARY ADENOCARCINOMA: TUMOUR CELL GROWTH AND METASTATIC POTENTIAL

P. Musiani, A. Allione, A. Modesti, 1997, The Journal of pathology.

Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis

P. Lollini, P. Nanni, A. Palladini, 2008, Pathology & Oncology Research.

Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.

P. Lollini, P. Nanni, C. De Giovanni, 2007, Oncology reports.

Immunological and non‐immunological influence of H‐2Kb gene transfection on the metastatic ability of B16 melanoma cells

P. Lollini, P. Tazzari, A. Santoni, 1991, International journal of cancer.

Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma

R. Versteeg, P. Picci, C. Hattinger, 2013, British Journal of Cancer.

Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.

E. Dejana, P. Lollini, E. Lalli, 1993, British Journal of Cancer.

Modulation by Ifn-Gamma of the Metastatic Ability of Murine, Human, and H-2-Transfected Tumor Cells

P. Lollini, K. Scotlandi, P. Nanni, 1989, Tumori.

Antimetastatic activity of a preventive cancer vaccine.

P. Musiani, P. Lollini, M. Iezzi, 2007, Cancer research.

Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.

P. Lollini, P. Nanni, C. De Giovanni, 1993, British Journal of Cancer.

A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome.

P. Musiani, M. Penichet, P. Lollini, 2009, Human gene therapy.

Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4

P. Lollini, P. Nanni, C. De Giovanni, 2009, Molecular Cancer Therapeutics.

Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role.

P. Lollini, P. Nanni, C. De Giovanni, 2006, European journal of cancer.

Production of stem cell factor and expression of c‐kit in human rhabdomyosarcoma cells: Lack of autocrine growth modulation

P. Lollini, P. Strippoli, P. Nanni, 1998, International journal of cancer.

Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells.

P. Lollini, P. Nanni, C. De Giovanni, 1996, Cancer research.

Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.

P. Lollini, M. Colombo, P. Nanni, 1995, British Journal of Cancer.

Antimetastatic activity of a preventive cancer vaccine (Cancer Research (2007) 67, (11037-11044))

P. Musiani, P. Lollini, M. Iezzi, 2007 .

Carcinomas in Transgenic BALB/c Mice Carcinogenesis Than Transplantable p185 More Effectively Inhibits DNA Vaccination Against Rat Her-2/Neu

P. Musiani, P. Lollini, M. Colombo, 2000 .

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

P. Lollini, C. García-echeverría, K. Scotlandi, 2010, European journal of cancer.

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

P. Lollini, M. Colombo, P. Nanni, 2018, Oncoimmunology.

CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality

P. Lollini, P. Lanuti, L. Landuzzi, 2022, Journal of Hematology & Oncology.

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma

P. Lollini, S. Petrini, A. Martelli, 2022, Cell Death & Disease.

NVP-BEZ235 as a New Therapeutic Option for Sarcomas

P. Lollini, C. García-echeverría, P. Picci, 2010, Clinical Cancer Research.

Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs.

P. Lollini, K. Scotlandi, P. Nanni, 1989, Cancer research.

Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.

P. Musiani, P. Lollini, A. Modesti, 1993, International journal of cancer.

H‐2Kb AND H‐2Db gene transfections in B16 melanoma differently affect non‐immunological properties relevant to the metastatic process. Involvement of integrin molecules

P. Lollini, A. Santoni, P. Nanni, 1994, International journal of cancer.

Expression of interleukin 15 (IL‐15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma

P. Lollini, N. Baldini, A. Santoni, 1997, International journal of cancer.

Preclinical In vivo Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma

C. Nanni, P. Lollini, F. Hofmann, 2007, Clinical Cancer Research.

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

P. Lollini, P. Nanni, C. De Giovanni, 2019, BMC Cancer.

DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice1 2

Piero Musiani, Patrizia Nanni, Guido Forni, 2000, The Journal of Immunology.

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Ilaria Rossi, 1998, The Journal of experimental medicine.

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

P. Lollini, K. Scotlandi, M. Manara, 2021, Cells.

In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.

P. Lollini, L. Tessarollo, G. Azzarello, 1991, British Journal of Cancer.

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model

P. Lollini, P. Nanni, C. De Giovanni, 2019, Cancers.

The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells.

P. Musiani, P. Lollini, G. Forni, 1998, Human gene therapy.

HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response.

P. Lollini, D. Santini, M. Iezzi, 2017, Oncotarget.

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma

P. Lollini, K. Scotlandi, M. Pasello, 2021, Cancer research.

Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice

P. Lollini, P. Nanni, A. Palladini, 2013, Oncotarget.

Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research

P. Lollini, K. Scotlandi, L. Landuzzi, 2023, Cancers.

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

S. Bicciato, M. Iezzi, M. Arigoni, 2014, BMC Genomics.

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression

P. Lollini, M. Arigoni, R. Calogero, 2021, Oncogenesis.

Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET

C. Nanni, S. Fanti, P. Lollini, 2010, Molecular Imaging and Biology.

Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer.

C. Nanni, S. Fanti, P. Lollini, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Multidrug resistance and malignancy in human osteosarcoma.

A. Colacci, P. Picci, F. Bertoni, 1996, Cancer research.

Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS–FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity

M. Negrini, P. Lollini, M. Magnani, 2021, Molecular Cancer Therapeutics.

Biological indicators of prognosis in Ewing's sarcoma: An emerging role for lectin galactoside‐binding soluble 3 binding protein (LGALS3BP)

S. Iacobelli, A. Llombart‐Bosch, P. Lollini, 2010, International journal of cancer.

Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene

P. Musiani, P. Lollini, G. Forni, 1993 .

New target antigens for cancer immunoprevention.

P. Lollini, P. Nanni, C. De Giovanni, 2005, Current cancer drug targets.

Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET

C. Nanni, D. Rubello, S. Fanti, 2010, Journal of experimental & clinical cancer research : CR.

Interleukin 12 gene therapy of MHC-negative murine melanoma metastases.

P. Lollini, M. Colombo, A. Stoppacciaro, 1998, Cancer research.

Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model

C. Nanni, S. Fanti, P. Lollini, 2009, Clinical and Experimental Medicine.

c-kit Receptor E xpression i n E wing's S arcoma: L ack o f Prognostic V alue b ut T herapeutic T argeting O pportunities i n Appropriate C onditions

P. Lollini, P. Picci, F. Bertoni, 2003 .

The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.

P. Lollini, K. Scotlandi, P. Nanni, 2000, The American journal of pathology.

Murine model for skeletal metastases of Ewing's sarcoma

P. Lollini, P. Picci, N. Baldini, 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent finding.

P. Lollini, G. Zauli, K. Scotlandi, 1989, European journal of cancer & clinical oncology.

Multidrug Resistance and Malignancy in Human Osteosarcoma 1 Katia Scotland !

A. Colacci, F. Bertoni, G. Bacci, 2006 .

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2

M. Penichet, P. Lollini, M. Iezzi, 2014, Breast Cancer Research.

Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2001, The Journal of experimental medicine.

Cancer immunoprevention: from mice to early clinical trials

P. Lollini, P. Nanni, A. Palladini, 2018, BMC Immunology.

Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug

P. Lollini, P. Picci, A. Belfiore, 2013, PloS one.

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

P. Lollini, P. Picci, P. Nanni, 2014, Oncotarget.

Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.

P. Lollini, P. Nanni, C. De Giovanni, 2001, Gene.

Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells.

P. Lollini, G. D’Orazi, S. Soddu, 1998, British Journal of Cancer.

Molecular and cellular biology of rhabdomyosarcoma.

P. Lollini, P. Nanni, C. De Giovanni, 2009, Future oncology.

Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells

P. Lollini, P. Picci, S. Avnet, 2002, International journal of cancer.

Inhibition of prostate carcinogenesis by combined active immunoprophylaxis

P. Musiani, P. Lollini, R. Kennedy, 2007, International journal of cancer.

Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2005, The American journal of pathology.

Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-γ

P. Musiani, P. Lollini, G. Forni, 2001, Gene Therapy.

Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine

Piero Musiani, Federica Cavallo, Annalisa Astolfi, 2004, Cancer Research.

Immunoprevention of Mammary Carcinoma in HER-2/neu Transgenic Mice Is IFN-γ and B Cell Dependent1

P. Musiani, P. Lollini, G. Forni, 2004, The Journal of Immunology.

Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.

P. Lollini, N. Baldini, K. Scotlandi, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Inhibition of Lung Colonisation of a Mouse Mammary Carcinoma by Therapeutic Vaccination with Interferon-α Gene-Transduced Tumor Cells

Flavia Frabetti, Filippo Belardelli, Piero Musiani, 1998, Clinical & Experimental Metastasis.

Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine

P. Lollini, J. Dorosz, Nicolaas A A Buijs, 2022, Biomedicines.

Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.

P. Lollini, P. Nanni, C. De Giovanni, 1992, British Journal of Cancer.

Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor

P. Lollini, M. Iezzi, P. Nanni, 2012, PloS one.

Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma

P. Lollini, A. Bazzocchi, K. Scotlandi, 2020, Journal of Cell Communication and Signaling.

A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy

A. Mai, P. Lollini, P. Picci, 2018, Molecular Cancer Therapeutics.

SARG: a new human osteosarcoma cell line. Expression of bone markers and of major histocompatibility antigens.

N. Baldini, K. Scotlandi, M. Serra, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC

M. Ferracin, P. Lollini, M. Fiorentino, 2022, Translational lung cancer research.

Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells.

P. Lollini, K. Scotlandi, P. Nanni, 1991, Invasion & metastasis.

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

P. Musiani, P. Lollini, M. Iezzi, 2009, Vaccine.

Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon.

P. Lollini, E. Lalli, P. Nanni, 1992, British Journal of Cancer.

Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma

P. Lollini, P. Tazzari, K. Scotlandi, 1990, Clinical & Experimental Metastasis.

Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

P. Lollini, P. Nanni, C. De Giovanni, 2009, Proceedings of the National Academy of Sciences.

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity

P. Lollini, K. Scotlandi, D. Donati, 2019, Journal of Experimental & Clinical Cancer Research.

Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.

P. Lollini, P. Picci, N. Baldini, 1998, Cancer research.

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy

P. Lollini, P. Picci, A. Caccuri, 2011, Analytical cellular pathology.

The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis.

A. Marchetti, F. Buttitta, A. Paradiso, 2009, The International journal of biological markers.

Apc10.1: An ApcMin/+ intestinal cell line with retention of heterozygosity

P. Lollini, P. Nanni, C. De Giovanni, 2004, International journal of cancer.

Expression of transduced carcinoembryonic antigen gene in human rhabdomyosarcoma inhibits metastasis.

P. Lollini, A. Santoni, P. Nanni, 1996, Cancer research.

An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma.

P. Lollini, P. Nanni, C. De Giovanni, 2001, European journal of cancer.

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R

P. Lollini, A. Amici, P. Nanni, 2019, Cancers.

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

P. Lollini, P. Nanni, C. De Giovanni, 2019, BMC Cancer.

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.

P. Lollini, P. Nanni, C. De Giovanni, 2011, Vaccine.

Cancer Vaccines Co-Targeting HER 2 / Neu and IGF 1 R

P. Lollini, A. Amici, P. Nanni, 2019 .

Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.

P. Lollini, G. Forni, A. Modica, 1995, Human gene therapy.

Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent.

P. Musiani, P. Lollini, G. Forni, 2004, Journal of immunology.

Vaccines and other immunological approaches for cancer immunoprevention.

Federica Cavallo, Patrizia Nanni, Guido Forni, 2011, Current drug targets.

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma

P. Lollini, K. Scotlandi, M. Manara, 2023, Cancers.

Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.

C. Dominici, G. Kokai, S. Uccini, 2008, Anticancer research.

IL-1 Family Members in Bone Sarcomas

M. Manara, L. Landuzzi, P. Lollini, 2024, Cells.

CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1‐targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape

M. Pasello, M. Manara, L. Landuzzi, 2024, Journal of cell communication and signaling.